More immunocompromised Australians now have free access to the shingles vaccine. This includes people on advanced treatments for autoimmune conditions. Could you be eligible?
If you have an autoimmune rheumatic disease, you have an increased risk of severe symptoms from respiratory infections. We share expert tips on managing your risks and staying healthy.
By CreakyStaff
Were you affected by the abatacept (Orencia®) shortage this year? If so, we have great news. The supply situation in Australia has improved and you may be able to return to your previous treatment regime.
Australians with moderate to severe lupus now have affordable access to a targeted treatment via the PBS for the first time.
Are you interested in the role health consumers play in planning and conducting health and medical research in Australia? Here’s your chance to have your say about how we can help shape the research that affects us.
By CreakyStaff
Do you use abatacept (Orencia®) to treat your inflammatory arthritis? Australia has a shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of abatacept. Here’s what you need to do.
Are you concerned about how women’s pain is handled across our health system? Allow us to share your thoughts and experiences in a new Inquiry into Women’s Pain.
By CreakyStaff
Australians with severe systemic lupus erythematosus may soon have a new treatment option. Here’s how you can help us get this medication subsidised through the Pharmaceutical Benefits Scheme.
The first Australian Rheumatoid Arthritis Clinical Care Standard aims to foster better health outcomes and an improved quality of care for people with RA across the country.
By CreakyStaff
Our guide to recognising osteoporosis risks, exploring treatment options and optimising dietary choices for better bone health.
By CreakyStaff
Exciting news for Australians with chronic plaque psoriasis. Two breakthrough treatments have been added to the PBS, bringing fresh possibilities for those with this challenging condition.
By CreakyStaff
Did you know children get arthritis, too? A new juvenile arthritis awareness campaign and a new research registry aim to improve the lives of young Australians with arthritis.
We're thrilled to support the global #AdvantageHers campaign by UCB, including women with lived experience of chronic inflammatory disease. Let's empower women to pursue their dreams and share their stories while seeking diagnosis and treatment.
By CreakyStaff
Were you transitioned to another medicine during the tocilizumab (Actemra®) shortage? Now that it is available again, you can speak with your rheumatologist about your ongoing treatment options.
By CreakyStaff
MyAS is a new website that helps people with axial spondyloarthritis/ankylosing spondylitis access tailored information about their condition.
A new Painaustralia report shows, since opioid regulations were tightened, 56.2 per cent of people with chronic pain have had their medication cut.
By CreakyStaff
Learn how you can help Arthritis Australia’s #1in7withArthritis 2022 election campaign to lobby federal parliamentarians for more support for people with arthritis.
By CreakyStaff
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
By CreakyStaff
Have you experienced delays in receiving scripts and biologic medication in the last two years? How has this affected you? Have your say in a new national survey.
By CreakyStaff
Limited supply of tocilizumab (Actemra®) is now on the way for some Australians with inflammatory conditions such as rheumatoid arthritis.
By CreakyStaff
In the Global Healthy Living Foundation’s latest COVID-19 Patient Support Program poll, the majority of respondents are not satisfied with their ability to socialise with others.
By CreakyStaff
Watch Michael Kuluva’s Tumbler and Tipsy 2022 Collection online event and see accessible fashion showcased by models with chronic conditions.
Guselkumab (Tremfya®) is a new treatment option for Australians with psoriatic arthritis – an autoimmune form of arthritis closely connected with psoriasis.
By CreakyStaff
How can Australians with autoimmune arthritis access a COVID-19 vaccine? Learn more about your eligibility and the evidence you will need to provide.
Tennis great, Caroline Wozniacki, is the face of the Advantage Hers campaign which helps women with chronic inflammation build their own health game plan.
Electronic prescription services are currently being rolled out in Australia. How do they work? How secure are they? Will they replace paper prescriptions?
What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
By CreakyStaff
CreakyJoints Australia launched the inaugural edition of A Patient’s Guide to Living with Axial Spondyloarthritis in Australia as a free download from their website today to coincide with World Arthritis Day.
By CreakyStaff
Due to COVID-19 restrictions and concerns, patients are delaying seeking the care they need to manage chronic conditions or to address new symptoms.
By CreakyStaff
Michael Kuluva has been using his fashion line Tumbler & Tipsy to raise awareness for arthritis and chronic illness for years — and he knew he had to find a COVID-friendly way to keep it going.
Australians are using more telehealth services due to COVID-19 but many are not maintaining their regular doctor visits for existing chronic conditions.
Australians hospitalised with severe COVID-19 symptoms can now access the newly approved drug remdesivir (Veklury®) to help speed their recovery time.
By CreakyStaff
This commonly prescribed steroid might be lifesaving for critically ill coronavirus patients.
Do you use opioid medication to manage your arthritis pain? If so, you need to know about the recent changes to Australian opioid access regulations.
By CreakyStaff
Do you use a biologic medication for your inflammatory arthritis? Do you know about biosimilars? Discover the basics as part of Biosimilar Awareness Week.
By CreakyStaff
Arthritis Australia, has launched MyRA - a new rheumatoid arthritis website designed to help people become active participants in their journey with the disease.
Axial spondyloarthritis (including ankylosing spondylitis) is a common form of arthritis, yet most Australians haven’t heard of it. CreakyJoints Australia would like to help change that.
By CreakyStaff
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
